(Q39463386)

12 September 2017

1 reference

title

Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update (English)

1 reference

12 September 2017

1 reference

Riddell JG

1

1 reference

12 September 2017

Harron DW

series ordinal

2

1 reference

12 September 2017

Shanks RG

series ordinal

3

1 reference

12 September 2017

1 May 1987

1 reference

Clinical Pharmacokinetics

12 September 2017

1 reference

12 September 2017

12

1 reference

12 September 2017

5

1 reference

12 September 2017

305-320

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198712050-00001

12 September 2017

0 references

cites work

A study of practolol elimination in all grades of chronic renal failure

1 reference

12 December 2020

Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment

1 reference

12 December 2020

Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man

1 reference

12 December 2020

Atenolol elimination in the neonate

1 reference

12 December 2020

Pindolol availability in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications

1 reference

12 December 2020

Differential effects of atenolol and enalapril on memory during treatment for essential hypertension

1 reference

12 December 2020

Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.

1 reference

12 December 2020

Beta-adrenoceptor blocking drugs and the elderly

1 reference

12 December 2020

Enzyme induction and beta-adrenergic receptor blocking drugs

1 reference

12 December 2020

Massive propranolol metabolite retention during maintenance hemodialysis

1 reference

12 December 2020

Importance of drug enantiomers in clinical pharmacology

1 reference

12 December 2020

Elimination kinetics of labetalol in severe renal failure

1 reference

12 December 2020

Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol

1 reference

12 December 2020

Drug metabolites in renal failure: pharmacokinetic and clinical implications

1 reference

12 December 2020

Use of labetalol in the treatment of severe hypertension during pregnancy

1 reference

12 December 2020

Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents

1 reference

12 December 2020

Pregnancy-induced increase in metoprolol metabolism

1 reference

12 December 2020

Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris

1 reference

12 December 2020

Pharmacokinetics of drugs in obesity

1 reference

12 December 2020

Drug interactions with cimetidine

1 reference

12 December 2020

Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc‐SA)

1 reference

12 December 2020

Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man

1 reference

12 December 2020

Drug Kinetics and Hepatic Blood Flow

1 reference

12 December 2020

Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation

1 reference

12 December 2020

Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension

1 reference

12 December 2020

beta-blocker plasma concentrations and inflammatory disease: clinical implications

1 reference

12 December 2020

Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactions

1 reference

12 December 2020

Propranolol--a medical treatment for portal hypertension?

1 reference

12 December 2020

Beta-blocker brain concentrations in man.

1 reference

12 December 2020

Drug Kinetics in Pregnancy

1 reference

12 December 2020

Kinetics and absolute bioavailability of atenolol

1 reference

12 December 2020

The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations

1 reference

12 December 2020

Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?

1 reference

12 December 2020

Effects of inflammatory disease on plasma oxprenolol concentrations

1 reference

12 December 2020

Propranolol disposition in renal failure

1 reference

12 December 2020

Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition

1 reference

12 December 2020

Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Effects of age and cigarette smoking on propranolol disposition

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function

1 reference

12 December 2020

Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

1 reference

12 December 2020

The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration

1 reference

12 December 2020

Influence of Thyroid Dysfunction on Drug Pharmacokinetics

1 reference

12 December 2020

Atenolol kinetics in renal failure

1 reference

12 December 2020

Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate.

1 reference

12 December 2020

Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris

1 reference

12 December 2020

Altered plasma protein binding of drugs in thyroid disease

1 reference

12 December 2020

Antipyrine and propranolol disposition in malnutrition

1 reference

12 December 2020

Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents

1 reference

12 December 2020

Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man

1 reference

12 December 2020

An updated pKa listing of medicinal compounds

1 reference

12 December 2020

Pharmacokinetics in patients with cardiac failure

1 reference

12 December 2020

Slow release beta-adrenoceptor blocking drugs

1 reference

12 December 2020

Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.

1 reference

12 December 2020

A comparison of the pharmacokinetics of propranolol in obese and normal volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Disposition of metoprolol in the newborn [letter]

1 reference

12 December 2020

Timolol kinetics in chronic renal insufficiency

1 reference

12 December 2020

Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.

1 reference

12 December 2020

Letter: Plasma-propranolol levels in inflammation disease

1 reference

12 December 2020

Pharmacokinetic Drug Interactions with Propranolol

1 reference

12 December 2020

Preliminary observations on the elimination of acebutolol in severe chronic renal failure

1 reference

12 December 2020

Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprolol

1 reference

12 December 2020

Role of tobacco smoking in pharmacokinetics

1 reference

12 December 2020

Gastrointestinal absorption of drugs

1 reference

12 December 2020

Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol

1 reference

12 December 2020

Clinical Pharmacokinetics of ??-Adrenoceptor Blocking Drugs in Thyroid Disease

1 reference

12 December 2020

Drug Metabolism and Pharmacokinetics in Malnutrition

1 reference

12 December 2020

Acebutolol disposition after intravenous administration.

1 reference

12 December 2020

The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol

1 reference

12 December 2020

Clinical pharmacokinetics of metoprolol

1 reference

12 December 2020

Excretion of oxprenolol and timolol in breast milk

1 reference

12 December 2020

Blood plasma binding of acebutolol and diacetolol in man.

1 reference

12 December 2020

Clinical Pharmacokinetics of β-Adrenoreceptor Blocking Drugs

1 reference

12 December 2020

Hepatic disease and drug pharmacokinetics

1 reference

12 December 2020

Drug Absorption in Gastrointestinal Disease With Particular Reference to Malabsorption Syndromes

1 reference

12 December 2020

Disease-induced changes in the plasma binding of basic drugs

1 reference

12 December 2020

Influence of Food Intake on Presystemic Clearance of Drugs

1 reference

12 December 2020

Sotalol as a hypotensive agent in pregnancy

1 reference

12 December 2020

Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy

1 reference

12 December 2020

Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers

1 reference

12 December 2020

Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug

1 reference

12 December 2020

Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents

1 reference

12 December 2020

The interaction of cigarette smoking and beta-adrenoceptor blockade

1 reference

12 December 2020

Influence of age and smoking on drug kinetics in man: studies using model compounds

1 reference

12 December 2020

Pharmacology of propranolol in patients with cirrhosis and portal hypertension

1 reference

12 December 2020

Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing

1 reference

12 December 2020

Pharmacokinetics of Metoprolol in Patients with Hepatic Cirrhosis

1 reference

12 December 2020

Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents

1 reference

12 December 2020

Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.

1 reference

12 December 2020

Plasma binding and the affinity of propranolol for a beta receptor in man

1 reference

12 December 2020

Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol

1 reference

12 December 2020

Influence of Food on the Bioavailability of Drugs

1 reference

12 December 2020

Current concepts: beta-blockers in pregnancy

1 reference

12 December 2020

Elimination of nadolol by patients with renal impairment

1 reference

12 December 2020

Binding of?-adrenoceptor blocking drugs to human serum albumin, to ?1-acid glycoprotein and to human serum

1 reference

12 December 2020

Pharmacokinetic aspects of some β-adrenoceptor blocking drugs

1 reference

12 December 2020

Labetalol disposition and concentration-effect relationships during pregnancy

1 reference

12 December 2020

Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

1 reference

12 December 2020

Clinical Pharmacokinetics of Labetalol

1 reference

12 December 2020

10.2165/00003088-198712050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

0 references

1 reference